(Q46800256)

25 December 2017

title

SNPs and taxane toxicity in breast cancer patients (English)

1 reference

25 December 2017

Virginia Bosó

1

0 references

María José Herrero

object named as

María José Herrero

2

0 references

author name string

Ana Santaballa

3

1 reference

25 December 2017

Laura Palomar

4

1 reference

25 December 2017

Juan E Megias

5

1 reference

25 December 2017

Helena de la Cueva

6

1 reference

25 December 2017

Luis Rojas

7

1 reference

25 December 2017

María Remedios Marqués

8

1 reference

25 December 2017

José Luis Poveda

9

1 reference

25 December 2017

Joaquin Montalar

10

1 reference

25 December 2017

Salvador F Aliño

11

1 reference

25 December 2017

publication date

1 January 2014

1 reference

25 December 2017

published in

Pharmacogenomics

1 reference

25 December 2017

volume

15

1 reference

25 December 2017

issue

15

1 reference

25 December 2017

page(s)

1845-1858

1 reference

25 December 2017

Pharmacogenetics of breast cancer therapies

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenetics in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Part 1: background, methodology, and clinical adoption of pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Advances in breast cancer: pathways to personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenomics of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Germline pharmacogenetics of paclitaxel for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Direct effect of Taxol on free radical formation and mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Paclitaxel induces apoptosis in breast cancer cells through different calcium--regulating mechanisms depending on external calcium conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Repression of gene expression by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenomics knowledge for personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Managing premedications and the risk for reactions to infusional monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenetic pathway analysis of docetaxel elimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Pharmacogenomics of taxane/platinum therapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

Phenyl N-tert-butylnitrone, a free radical scavenger, reduces mechanical allodynia in chemotherapy-induced neuropathic pain in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.14.127

21 January 2018

Identifiers

DOI

10.2217/PGS.14.127

1 reference

25 December 2017

1 reference

25 December 2017